{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:54:45Z","timestamp":1793408085073,"version":"4.5.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.amjmed.2022.09.025","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T06:11:19Z","timestamp":1665727879000},"page":"42-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["A Practical Guide for Primary Care Providers on Timely Diagnosis and Comprehensive Care Strategies for Hidradenitis Suppurativa"],"prefix":"10.1016","volume":"136","author":[{"given":"Amit","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley B.","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joslyn S.","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.amjmed.2022.09.025_bib0001","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaad.2019.02.067","article-title":"North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management","volume":"81","author":"Alikhan","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"5 suppl 1","key":"10.1016\/j.amjmed.2022.09.025_bib0002","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jaad.2015.07.052","article-title":"Hidradenitis suppurativa: epidemiology and scope of the problem","volume":"73","author":"Jemec","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.amjmed.2022.09.025_bib0003","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/jid.2012.255","article-title":"Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota","volume":"133","author":"Vazquez","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"8","key":"10.1016\/j.amjmed.2022.09.025_bib0004","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/jamadermatol.2017.0201","article-title":"Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States","volume":"153","author":"Garg","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.amjmed.2022.09.025_bib0005","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaad.2017.02.005","article-title":"Incidence of hidradenitis suppurativa in the United States: a sex- and age-adjusted population analysis","volume":"77","author":"Garg","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.amjmed.2022.09.025_bib0006","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1001\/jamadermatol.2019.0478","article-title":"Distribution of self-reported hidradenitis suppurativa age at onset","volume":"155","author":"Naik","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.amjmed.2022.09.025_bib0007","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","article-title":"Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies","volume":"59","author":"Revuz","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.amjmed.2022.09.025_bib0008","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.jid.2018.04.001","article-title":"Prevalence estimates for hidradenitis suppurativa among children and adolescents in the United States: a gender- and age-adjusted population analysis","volume":"138","author":"Garg","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.amjmed.2022.09.025_bib0009","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41702-019-0052-0","article-title":"Global prevalence of hidradenitis suppurativa and geographical variation\u2014systematic review and meta-analysis","volume":"4","author":"Phan","year":"2020","journal-title":"Biomed Dermatol"},{"issue":"2","key":"10.1016\/j.amjmed.2022.09.025_bib0010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1203475420972348","article-title":"Race-specific prevalence of hidradenitis suppurativa","volume":"25","author":"Sachdeva","year":"2021","journal-title":"J Cutan Med Surg"},{"issue":"8","key":"10.1016\/j.amjmed.2022.09.025_bib0011","doi-asserted-by":"crossref","first-page":"990","DOI":"10.2340\/00015555-2176","article-title":"Hidradenitis suppurativa disproportionately affects African Americans: a single-center retrospective analysis","volume":"95","author":"Vlassova","year":"2015","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.amjmed.2022.09.025_bib0012","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaad.2019.06.1301","article-title":"Evaluating patients' unmet needs in hidradenitis suppurativa: results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project","volume":"82","author":"Garg","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.amjmed.2022.09.025_bib0013","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/jdv.16132","article-title":"Baseline patient-reported outcomes from UNITE: an observational, international, multicentre registry to evaluate hidradenitis suppurativa in clinical practice","volume":"34","author":"Kimball","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.amjmed.2022.09.025_bib0014","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/PROM.S174299","article-title":"An update on health-related quality of life and patient-reported outcomes in hidradenitis suppurativa","volume":"11","author":"Mac Mahon","year":"2020","journal-title":"Patient Relat Outcome Meas"},{"issue":"4","key":"10.1016\/j.amjmed.2022.09.025_bib0015","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/bjd.14976","article-title":"High burden of hospital resource utilization in patients with hidradenitis suppurativa in England: a retrospective cohort study using hospital episode statistics","volume":"176","author":"Desai","year":"2017","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.amjmed.2022.09.025_bib0016","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jaad.2015.06.053","article-title":"Increased utilization of emergency department and inpatient care by patients with hidradenitis suppurativa","volume":"73","author":"Khalsa","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.amjmed.2022.09.025_bib0017","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jamadermatol.2014.691","article-title":"Health care utilization patterns and costs for patients with hidradenitis suppurativa","volume":"150","author":"Kirby","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.amjmed.2022.09.025_bib0018","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jaad.2021.01.059","article-title":"Comorbidity screening in hidradenitis suppurativa: evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations","volume":"86","author":"Garg","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.amjmed.2022.09.025_bib0019","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jamadermatol.2019.0164","article-title":"Comparative overall comorbidity burden among patients with hidradenitis suppurativa","volume":"155","author":"Reddy","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.amjmed.2022.09.025_bib0020","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/bjd.19435","article-title":"The epidemiology of hidradenitis suppurativa","volume":"183","author":"Ingram","year":"2020","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.amjmed.2022.09.025_bib0021","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.amjmed.2022.09.025_bib0022","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/jamadermatol.2020.5467","article-title":"Global harmonization of morphological definitions in hidradenitis suppurativa for a proposed glossary","volume":"157","author":"Frew","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.amjmed.2022.09.025_bib0023","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/12034754211024157","article-title":"Hidradenitis suppurativa from a patient perspective including symptoms and self-treatment","volume":"25","author":"Huang","year":"2021","journal-title":"J Cutan Med Surg"},{"issue":"4","key":"10.1016\/j.amjmed.2022.09.025_bib0024","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jid.2019.08.445","article-title":"Skin microbiota perturbations are distinct and disease severity-dependent in hidradenitis suppurativa","volume":"140","author":"Naik","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.amjmed.2022.09.025_bib0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaad.2019.02.068","article-title":"North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: part II: topical, intralesional, and systemic medical management","volume":"81","author":"Alikhan","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.amjmed.2022.09.025_bib0026","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1159\/000508787","article-title":"Delayed diagnosis of hidradenitis suppurativa and its effect on patients and healthcare system","volume":"236","author":"Kokolakis","year":"2020","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.amjmed.2022.09.025_bib0027","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1601-0825.2008.01463.x","article-title":"Hyper IgE (Job's) syndrome: a primary immune deficiency with oral manifestations","volume":"15","author":"Freeman","year":"2009","journal-title":"Oral Dis"},{"issue":"4","key":"10.1016\/j.amjmed.2022.09.025_bib0028","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jaad.2019.06.016","article-title":"All-cause mortality among patients with hidradenitis suppurativa: a population-based cohort study in the United States","volume":"81","author":"Reddy","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.amjmed.2022.09.025_bib0029","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jid.2018.01.009","article-title":"Hidradenitis suppurativa is associated with polycystic ovary syndrome: a population-based analysis in the United States","volume":"138","author":"Garg","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.amjmed.2022.09.025_bib0030","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jaad.2014.09.012","article-title":"Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis","volume":"71","author":"Shlyankevich","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.amjmed.2022.09.025_bib0031","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jaad.2013.11.014","article-title":"The prevalence of metabolic syndrome in patients with hidradenitis suppurativa","volume":"70","author":"Gold","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.amjmed.2022.09.025_bib0032","doi-asserted-by":"crossref","first-page":"e31810","DOI":"10.1371\/journal.pone.0031810","article-title":"Increased prevalence of metabolic syndrome in patients with acne inversa","volume":"7","author":"Sabat","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.amjmed.2022.09.025_bib0033","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2017.08.042","article-title":"Hidradenitis suppurativa and diabetes mellitus: a systematic review and meta-analysis","volume":"78","author":"Bui","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.amjmed.2022.09.025_bib0034","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jaad.2018.01.014","article-title":"Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States","volume":"79","author":"Garg","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.amjmed.2022.09.025_bib0035","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s13555-018-0264-z","article-title":"The comorbidity burden of hidradenitis suppurativa in the United States: a claims data analysis","volume":"8","author":"Kimball","year":"2018","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"12","key":"10.1016\/j.amjmed.2022.09.025_bib0036","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/jamadermatol.2014.1165","article-title":"Association of metabolic syndrome and hidradenitis suppurativa","volume":"150","author":"Miller","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.amjmed.2022.09.025_bib0037","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/bjd.14024","article-title":"Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies","volume":"173","author":"Tzellos","year":"2015","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.amjmed.2022.09.025_bib0038","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jamadermatol.2015.6264","article-title":"Risk of major adverse cardiovascular events and all-cause mortality in patients with hidradenitis suppurativa","volume":"152","author":"Egeberg","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.amjmed.2022.09.025_bib0039","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamadermatol.2019.3412","article-title":"Incidence of myocardial infarction and cerebrovascular accident in patients with hidradenitis suppurativa","volume":"156","author":"Reddy","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.amjmed.2022.09.025_bib0040","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaad.2021.06.023","article-title":"Adverse pregnancy and maternal outcomes in women with hidradenitis suppurativa","volume":"86","author":"Fitzpatrick","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.amjmed.2022.09.025_bib0041","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jid.2016.11.040","article-title":"Prevalence and risk of inflammatory bowel disease in patients with hidradenitis suppurativa","volume":"137","author":"Egeberg","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"7","key":"10.1016\/j.amjmed.2022.09.025_bib0042","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jamadermatol.2018.0878","article-title":"Overall and subgroup prevalence of Crohn disease among patients with hidradenitis suppurativa: a population-based analysis in the United States","volume":"154","author":"Garg","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.amjmed.2022.09.025_bib0043","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jbspin.2017.09.005","article-title":"Association between hidradenitis suppurativa and spondyloarthritis","volume":"85","author":"Fauconier","year":"2018","journal-title":"Joint Bone Spine"},{"issue":"10","key":"10.1016\/j.amjmed.2022.09.025_bib0044","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1111\/jdv.15071","article-title":"Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population-based study","volume":"32","author":"Lee","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.amjmed.2022.09.025_bib0045","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1001\/jamadermatol.2019.0759","article-title":"Depression and anxiety in adults with hidradenitis suppurativa: a systematic review and meta-analysis","volume":"155","author":"Machado","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.amjmed.2022.09.025_bib0046","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1468-3083.2012.04468.x","article-title":"Depression in patients with hidradenitis suppurativa","volume":"27","author":"Onderdijk","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.amjmed.2022.09.025_bib0047","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jdv.12567","article-title":"Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa","volume":"29","author":"Shavit","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.amjmed.2022.09.025_bib0048","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/bjd.16998","article-title":"Prevalence of patients with self-reported hidradenitis suppurativa in a cohort of Danish blood donors: a cross-sectional study","volume":"180","author":"Theut Riis","year":"2019","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.amjmed.2022.09.025_bib0049","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jid.2017.09.008","article-title":"Increased suicide risk in patients with hidradenitis suppurativa","volume":"138","author":"Thorlacius","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.amjmed.2022.09.025_bib0050","first-page":"502","article-title":"Incidence of sexual dysfunction among patients with hidradenitis suppurativa: a population-based retrospective analysis","volume":"179","author":"Slyper","year":"2018","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.amjmed.2022.09.025_bib0051","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/bjd.15939","article-title":"Incidence of hidradenitis suppurativa among tobacco smokers: a population-based retrospective analysis in the U.S.A","volume":"178","author":"Garg","year":"2018","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.amjmed.2022.09.025_bib0052","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jaad.2018.02.053","article-title":"Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: a population-based analysis in the United States","volume":"79","author":"Garg","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.amjmed.2022.09.025_bib0053","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1001\/jamadermatol.2019.2610","article-title":"Incidence of long-term opioid use among opioid-naive patients with hidradenitis suppurativa in the United States","volume":"155","author":"Reddy","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.amjmed.2022.09.025_bib0054","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jaad.2014.04.001","article-title":"Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity","volume":"71","author":"Schrader","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.amjmed.2022.09.025_bib0055","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/bjd.19713","article-title":"Trends in body mass index before and after diagnosis of hidradenitis suppurativa","volume":"185","author":"Wright","year":"2021","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.amjmed.2022.09.025_bib0056","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2340\/00015555-2967","article-title":"Influence of itch and pain on sleep quality in patients with hidradenitis suppurativa","volume":"98","author":"Kaaz","year":"2018","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.amjmed.2022.09.025_bib0057","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2340\/00015555-2815","article-title":"Clinical characteristics of pruritus and pain in patients with hidradenitis suppurativa","volume":"98","author":"Matusiak","year":"2018","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.amjmed.2022.09.025_bib0058","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2340\/00015555-2129","article-title":"Disutility in patients with hidradenitis suppurativa: a cross-sectional study using EuroQoL-5D","volume":"96","author":"Riis","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.amjmed.2022.09.025_bib0059","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s40257-017-0280-2","article-title":"Assessing pruritus in hidradenitis suppurativa: a cross-sectional study","volume":"18","author":"Vossen","year":"2017","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"10.1016\/j.amjmed.2022.09.025_bib0060","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/bjd.18707","article-title":"Standing up together to the shame and stigma associated with hidradenitis suppurativa","volume":"182","author":"Kirby","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.amjmed.2022.09.025_bib0061","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2147\/CCID.S180036","article-title":"Perspectives on perceived stigma and self-stigma in patients with hidradenitis suppurativa","volume":"12","author":"Koumaki","year":"2019","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"4","key":"10.1016\/j.amjmed.2022.09.025_bib0062","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/jamadermatol.2017.6058","article-title":"Association of hidradenitis suppurativa with body image","volume":"154","author":"Schneider-Burrus","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.amjmed.2022.09.025_bib0063","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijwd.2017.10.007","article-title":"Quality of life and sexual health in patients with hidradenitis suppurativa","volume":"4","author":"Alavi","year":"2018","journal-title":"Int J Womens Dermatol"},{"issue":"4","key":"10.1016\/j.amjmed.2022.09.025_bib0064","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/bjd.14975","article-title":"Sexual health and quality of life are impaired in hidradenitis suppurativa: a multicentre cross-sectional study","volume":"176","author":"Janse","year":"2017","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.amjmed.2022.09.025_bib0065","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jid.2017.06.020","article-title":"Patients with hidradenitis suppurativa have a high psychiatric disease burden: a Finnish nationwide registry study","volume":"138","author":"Huilaja","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.amjmed.2022.09.025_bib0066","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/bjd.16101","article-title":"Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa","volume":"178","author":"Ingram","year":"2018","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.amjmed.2022.09.025_bib0067","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1016\/j.jid.2018.06.171","article-title":"Women with hidradenitis suppurativa have an elevated risk of suicide","volume":"138","author":"Tiri","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"9","key":"10.1016\/j.amjmed.2022.09.025_bib0068","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-030579","article-title":"Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data","volume":"9","author":"Marvel","year":"2019","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.amjmed.2022.09.025_bib0069","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/bjd.17416","article-title":"Association between hidradenitis suppurativa and hospitalization for psychiatric disorders: a cross-sectional analysis of the National Inpatient Sample","volume":"181","author":"Patel","year":"2019","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.amjmed.2022.09.025_bib0070","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1468-3083.2000.00087.x","article-title":"The natural history of hidradenitis suppurativa","volume":"14","author":"von der Werth","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.amjmed.2022.09.025_bib0071","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/jid.2012.372","article-title":"gamma-Secretase mutations in hidradenitis suppurativa: new insights into disease pathogenesis","volume":"133","author":"Pink","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.amjmed.2022.09.025_bib0072","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.3389\/fimmu.2018.02965","article-title":"Hidradenitis suppurativa: a systematic review integrating inflammatory pathways into a cohesive pathogenic model","volume":"9","author":"Vossen","year":"2018","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.amjmed.2022.09.025_bib0073","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.jid.2016.04.036","article-title":"Intrinsic defect in keratinocyte function leads to inflammation in hidradenitis suppurativa","volume":"136","author":"Hotz","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"5 suppl 1","key":"10.1016\/j.amjmed.2022.09.025_bib0074","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.jaad.2015.07.045","article-title":"Pathophysiology of hidradenitis suppurativa: an update","volume":"73","author":"Prens","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjmed.2022.09.025_bib0075","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/CCID.S111019","article-title":"Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment","volume":"10","author":"Napolitano","year":"2017","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"5","key":"10.1016\/j.amjmed.2022.09.025_bib0076","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/17512433.2020.1762571","article-title":"The pharmacology of antibiotic therapy in hidradenitis suppurativa","volume":"13","author":"Marasca","year":"2020","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.amjmed.2022.09.025_bib0077","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.3390\/cells10082094","article-title":"Hidradenitis suppurativa: where we are and where we are going","volume":"10","author":"Scala","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.amjmed.2022.09.025_bib0078","first-page":"413","article-title":"Complement activation in hidradenitis suppurativa: a new pathway of pathogenesis?","volume":"179","author":"Kanni","year":"2018","journal-title":"Br J Dermatol"},{"issue":"22","key":"10.1016\/j.amjmed.2022.09.025_bib0079","doi-asserted-by":"crossref","first-page":"8436","DOI":"10.3390\/ijms21228436","article-title":"Cytokine pathways and investigational target therapies in hidradenitis suppurativa","volume":"21","author":"Del Duca","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.amjmed.2022.09.025_bib0080","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","article-title":"Elevated levels of tumour necrosis factor (TNF)-alpha, interleukin (IL)-1beta and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-alpha and IL-1beta","volume":"164","author":"van der Zee","year":"2011","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.amjmed.2022.09.025_bib0081","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jid.2018.11.018","article-title":"The IL-1 pathway is hyperactive in hidradenitis suppurativa and contributes to skin infiltration and destruction","volume":"139","author":"Witte-Handel","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.amjmed.2022.09.025_bib0082","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/bjd.14075","article-title":"Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa","volume":"173","author":"Kelly","year":"2015","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.amjmed.2022.09.025_bib0083","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaad.2010.07.010","article-title":"Expression of the IL-23\/Th17 pathway in lesions of hidradenitis suppurativa","volume":"65","author":"Schlapbach","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.amjmed.2022.09.025_bib0084","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/jamadermatol.2018.0141","article-title":"Association of hidradenitis suppurativa with T helper 1\/T helper 17 phenotypes: a semantic map analysis","volume":"154","author":"Thomi","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.amjmed.2022.09.025_bib0085","first-page":"239","article-title":"The role of androgens and estrogens in hidradenitis suppurativa \u2013 a systematic review","volume":"24","author":"Riis","year":"2016","journal-title":"Acta Dermatovenerol Croat"},{"issue":"5 suppl 1","key":"10.1016\/j.amjmed.2022.09.025_bib0086","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.jaad.2015.07.048","article-title":"Local wound care and topical management of hidradenitis suppurativa","volume":"73","author":"Alavi","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjmed.2022.09.025_bib0087","article-title":"Rifampin-moxifloxacin-metronidazole combination therapy for severe Hurley Stage 1 hidradenitis suppurativa: prospective short-term trial and one-year follow-up in 28 consecutive patients [online ahead of print]","author":"Delage","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.amjmed.2022.09.025_bib0088","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000321716","article-title":"Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa","volume":"222","author":"Join-Lambert","year":"2011","journal-title":"Dermatology"},{"issue":"6","key":"10.1016\/j.amjmed.2022.09.025_bib0089","first-page":"44","article-title":"Finasteride in hidradenitis suppurativa: a \"male\" therapy for a predominantly \"female\" disease","volume":"9","author":"Khandalavala","year":"2016","journal-title":"J Clin Aesthet Dermatol"},{"issue":"4","key":"10.1016\/j.amjmed.2022.09.025_bib0090","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2310\/7750.2007.00019","article-title":"Hidradenitis suppurativa in 64 female patients: retrospective study comparing oral antibiotics and antiandrogen therapy","volume":"11","author":"Kraft","year":"2007","journal-title":"J Cutan Med Surg"},{"issue":"9","key":"10.1016\/j.amjmed.2022.09.025_bib0091","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1468-3083.2012.04668.x","article-title":"Metformin for the treatment of hidradenitis suppurativa: a little help along the way","volume":"27","author":"Verdolini","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.amjmed.2022.09.025_bib0092","unstructured":"Humira (adalimumab). Package insert. North Chicago, Ill: AbbVie, Inc."},{"issue":"5","key":"10.1016\/j.amjmed.2022.09.025_bib0093","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa1504370","article-title":"Two phase 3 trials of adalimumab for hidradenitis suppurativa","volume":"375","author":"Kimball","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.amjmed.2022.09.025_bib0094","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaad.2018.05.040","article-title":"Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa\/acne inversa: 3-year results of a phase 3 open-label extension study","volume":"80","author":"Zouboulis","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.amjmed.2022.09.025_bib0095","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jaad.2020.02.005","article-title":"Secukinumab in the treatment of moderate to severe hidradenitis suppurativa: results of an open-label trial","volume":"82","author":"Casseres","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.amjmed.2022.09.025_bib0096","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/bjd.17822","article-title":"Open-label, investigator-initiated, single-site exploratory trial evaluating secukinumab, an anti-interleukin-17A monoclonal antibody, for patients with moderate-to-severe hidradenitis suppurativa","volume":"181","author":"Prussick","year":"2019","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.amjmed.2022.09.025_bib0097","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/bjd.14338","article-title":"Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum","volume":"174","author":"Blok","year":"2016","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.amjmed.2022.09.025_bib0098","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2340\/00015555-1229","article-title":"Management of recalcitrant hidradenitis suppurativa with ustekinumab","volume":"92","author":"Sharon","year":"2012","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.amjmed.2022.09.025_bib0099","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jaad.2013.09.044","article-title":"An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa","volume":"70","author":"Leslie","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.amjmed.2022.09.025_bib0100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jamadermatol.2015.3903","article-title":"Safety and efficacy of anakinra in severe hidradenitis suppurativa: a randomized clinical trial","volume":"152","author":"Tzanetakou","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"11","key":"10.1016\/j.amjmed.2022.09.025_bib0101","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1001\/jamadermatol.2021.2905","article-title":"Efficacy and safety of bimekizumab in moderate to severe hidradenitis suppurativa: a phase 2, double-blind, placebo-controlled randomized clinical trial","volume":"157","author":"Glatt","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.amjmed.2022.09.025_bib0102","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s13555-020-00391-x","article-title":"Office-based surgical intervention for hidradenitis suppurativa (HS): a focused review for dermatologists","volume":"10","author":"Saylor","year":"2020","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"1","key":"10.1016\/j.amjmed.2022.09.025_bib0103","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"issue":"9","key":"10.1016\/j.amjmed.2022.09.025_bib0104","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart Disease and Stroke Statistics\u20132020 update: a report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.amjmed.2022.09.025_bib0105","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","article-title":"The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test","volume":"158","author":"Bush","year":"1998","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.amjmed.2022.09.025_bib0106","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jaad.2014.11.038","article-title":"Chronic pain management in dermatology: pharmacotherapy and therapeutic monitoring with opioid analgesia","volume":"73","author":"Enamandram","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"535","key":"10.1016\/j.amjmed.2022.09.025_bib0107","first-page":"144","article-title":"Do ultra-short screening instruments accurately detect depression in primary care? A pooled analysis and meta-analysis of 22 studies","volume":"57","author":"Mitchell","year":"2007","journal-title":"Br J Gen Pract"},{"issue":"10","key":"10.1016\/j.amjmed.2022.09.025_bib0108","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.amjmed.2022.09.025_bib0109","article-title":"Patient health questionnaire depression scale as a suicide screening instrument in depressed primary care patients: a cross-sectional study","volume":"13","author":"Uebelacker","year":"2011","journal-title":"Prim Care Companion CNS Disord"},{"issue":"1","key":"10.1016\/j.amjmed.2022.09.025_bib0110","first-page":"adv00364","article-title":"Pain in hidradenitis suppurativa: a cross-sectional study of 1,795 patients","volume":"101","author":"Krajewski","year":"2021","journal-title":"Acta Derm Venereol"},{"issue":"13","key":"10.1016\/j.amjmed.2022.09.025_bib0111","doi-asserted-by":"crossref","first-page":"6709","DOI":"10.3390\/ijerph18136709","article-title":"The burden of hidradenitis suppurativa signs and symptoms in quality of life: systematic review and meta-analysis","volume":"18","author":"Montero-Vilchez","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"11","key":"10.1016\/j.amjmed.2022.09.025_bib0112","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/01.MLR.0000093487.78664.3C","article-title":"The Patient Health Questionnaire-2: validity of a two-item depression screener","volume":"41","author":"Kroenke","year":"2003","journal-title":"Med Care"},{"issue":"22","key":"10.1016\/j.amjmed.2022.09.025_bib0113","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1001\/jama.2020.6504","article-title":"Accuracy of the PHQ-2 alone and in combination with the PHQ-9 for screening to detect major depression: systematic review and meta-analysis","volume":"323","author":"Levis","year":"2020","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.amjmed.2022.09.025_bib0114","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"issue":"4","key":"10.1016\/j.amjmed.2022.09.025_bib0115","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/bjd.13090","article-title":"Risk factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study","volume":"171","author":"Kromann","year":"2014","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.amjmed.2022.09.025_bib0116","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2340\/00015555-1800","article-title":"The influence of body weight on the prevalence and severity of hidradenitis suppurativa","volume":"94","author":"Kromann","year":"2014","journal-title":"Acta Derm Venereol"},{"issue":"12","key":"10.1016\/j.amjmed.2022.09.025_bib0117","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9124046","article-title":"Prevalence of neuropathic pain and related characteristics in hidradenitis suppurativa: a cross-sectional study","volume":"9","author":"Garcovich","year":"2020","journal-title":"J Clin Med"},{"issue":"5 suppl 1","key":"10.1016\/j.amjmed.2022.09.025_bib0118","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jaad.2015.07.046","article-title":"Pain management in patients with hidradenitis suppurativa","volume":"73","author":"Horvath","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.amjmed.2022.09.025_bib0119","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jaad.2020.09.039","article-title":"Pain management in hidradenitis suppurativa and a proposed treatment algorithm","volume":"85","author":"Savage","year":"2021","journal-title":"J Am Acad Dermatol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934322007306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934322007306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:29:55Z","timestamp":1757582995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934322007306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":119,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0002934322007306"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2022.09.025","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Practical Guide for Primary Care Providers on Timely Diagnosis and Comprehensive Care Strategies for Hidradenitis Suppurativa","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2022.09.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}